Public annual accounts

DR PAULIEN JANSE financials

Name: DR PAULIEN JANSE financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DR PAULIEN JANSE, with comparable measures and links to available source documents.

Company overview

Registry number

0791933536

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for DR PAULIEN JANSE

2025 versus 2024

Operating line: €129,545
EBITDA: €128,731
Total assets: €191,831
Equity: €183,083

EBITDA margin +99.4% · Equity ratio +95.4%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€129,545	€128,731	€191,831	€183,083	-
202431 Dec 2024	€59,993	€59,811	€87,967	€82,613	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report